A detailed history of J. Safra Sarasin Holding Ag transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 26,690 shares of BMRN stock, worth $1.79 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
26,690
Holding current value
$1.79 Million
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$74.43 - $92.22 $1.99 Million - $2.46 Million
26,690 New
26,690 $2.2 Billion

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.